|
AU2008202255A1
|
|
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
|
|
AU2007201099A1
|
|
Alpha (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
WO2005120558A2
|
|
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
EP1601756A2
|
|
Methods for the preparation of alpha (2) macroglobulin-antigenic molecule complexes
|
|
CN1942199A
|
|
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
EP1594535A2
|
|
Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
|
|
WO2004069205A2
|
|
Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
|
|
US2006140966A1
|
|
Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
|
|
AU2004220627A1
|
|
Immunogenic CD19 ligand-antigenic molecule complexes and fusion proteins
|
|
AU2004208850A1
|
|
Immunogenic CD91 ligand-antigenic molecule complexes and fusion proteins
|
|
CA2515123A1
|
|
Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
|
|
AU2003301526A1
|
|
Immunotherapy of cancer through controlled cell lysis
|
|
AU2003301296A1
|
|
Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines
|
|
CA2483449A1
|
|
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
CA2514500A1
|
|
Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
|
|
CA2517274A1
|
|
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
US6984389B2
|
|
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
PL375043A1
|
|
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin, useful for the treatment of cancer and infectious disease
|
|
US2002172682A1
|
|
Using heat shock proteins to increase immune response
|
|
WO02058628A2
|
|
Immunotherapeutic methods for extracorporeal modulation of cd36 and its ligands
|
